TippingPoint Biosciences

United States · Biotech · AI · Healthtech

Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed$4.5MAmerican Cancer Society BrightEdge — Role not disclosedFreeflow Ventures — Role not disclosedLKS Fund — Role not disclosedSazze Partners — Role not disclosedSontag Innovation Fund — Role not disclosedSOSV — Role not disclosedStoryHouse Ventures — Role not disclosedWeCAN — Role not disclosedXEIA — Role not disclosed
Sourcestippingpointbiosciences.com ↗